drugset / Trial / NCT02622243
Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge
RandomizedCrossoverTriple-blindTreatment
Summary
The study will assess the duration of protection of single doses of 2 different long acting muscarinic antagonists against methacholine induced bronchoconstriction.
Timeline
- Start
- 2015-11
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrronium | Unknown | 50 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 5 ug | Inhaled |